These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 5396510

  • 1. Clinical pharmacology and in vitro activity of phosphonomycin.
    Kestle DG, Kirby WM.
    Antimicrob Agents Chemother (Bethesda); 1969; 9():332-7. PubMed ID: 5396510
    [No Abstract] [Full Text] [Related]

  • 2. Phosphonomycin. I. Discovery and in vitro biological characterization.
    Stapley EO, Hendlin D, Mata JM, Jackson M, Wallick H, Hernandez S, Mochales S, Currie SA, Miller RM.
    Antimicrob Agents Chemother (Bethesda); 1969; 9():284-90. PubMed ID: 5396502
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of phosphonomycin after oral administration in man.
    Foltz EL, Wallick H, Rosenblum C.
    Antimicrob Agents Chemother (Bethesda); 1969; 9():322-6. PubMed ID: 5396508
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phosphonomycin. IV. Susceptibility testing method and survey.
    Zimmerman SB, Stapley EO, Wallick H, Baldwin R.
    Antimicrob Agents Chemother (Bethesda); 1969; 9():303-9. PubMed ID: 5396505
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phosphonomycin (MK-955). Quantitative sensitivity spectra of various hospital strains to this new antibiotic.
    Moreno-López M, Dámaso D, Perea EJ, Sousa AS, Martínez L, Marco L.
    Microbiol Esp; 1971; 24(2):79-85. PubMed ID: 5135048
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Activation of phosphonomycin by gamma-globulin].
    Raab W, Windisch J.
    Arzneimittelforschung; 1973 Aug; 23(8):1029-30. PubMed ID: 4128970
    [No Abstract] [Full Text] [Related]

  • 11. [Tobramycin: pharmacology in man].
    Brogard JM, Harf C, Pinget M, Lavillaureix J.
    Nouv Presse Med; 1974 Apr 27; 3(0):59-64. PubMed ID: 4600180
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity and toxicity of bleomycin.
    Ishizuka M, Takayama H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1967 Jan 27; 20(1):15-24. PubMed ID: 6072277
    [No Abstract] [Full Text] [Related]

  • 19. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.
    J Okla State Med Assoc; 2006 Oct 27; 99(10):516-20. PubMed ID: 17125105
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.